“Our aim is to replace 25 - 40 percent of clinical visits with virtual visits, as it is still crucial for patients to meet physicians in person, especially for the first visit when they discuss the trial details and get dispensed study medication,” said Mark Hanley, Founder and CEO of VirTrial.
SCOTTSDALE, Ariz. (PRWEB) January 16, 2019
VirTrial, a virtual clinical trial platform, was recently recognized by CIOReview as one of the ‘20 most promising pharma & life sciences tech solution providers of 2018.’ The Innovative app also was selected as a finalist for the ‘Fierce Innovation Award – Life Sciences Edition 2018’ in the Digital Health Solutions Category, by FierceBiotech.
VirTrial’s mobile-friendly app is a new breed of virtual trial platform that provides a hybrid model for clinical trials that require a combination of in-clinic and virtual visits. Its combined video, text, and email platform is available to any clinical site, operates on any device, and provides interpreter services for 20 languages via video and 183 via audio.
“Our aim is to replace 25 - 40 percent of clinical visits with virtual visits, as it is still crucial for patients to meet physicians in person, especially for the first visit when they discuss the trial details and get dispensed study medication,” said Mark Hanley, Founder and CEO of VirTrial. “During the primary clinic visit, patients also undergo eligibility checks and physical examinations and get their medical records reviewed.”
The VirTrial app reduces the burden on patients by making participation fit more easily into their lives and enabling visits over video from their home or office. VirTrial also benefits research sites by providing them with analytical dashboard reports in real-time that enable them to make preemptive decisions with regard to patient activity.
Ultimately, VirTrial aims to make clinical trials more convenient for patients, more efficient for research sites, and to expedite the introduction of effective medications in the market.
For more information on VirTrial’s virtual clinical trial app, go to http://www.VirTrial.com.
VirTrial purchased and customized a stable, award-winning virtual care platform and customized it for clinical trial use to transform telehealth in the clinical research industry. VirTrial offers a post-approval management program that combines video, text, and email for clinical trial sites to easily, efficiently, and conveniently address specific patient and/or study needs. The platform can be used on any device and at any site. The company vision is to replace 25-40 percent of standard clinical trial visits with virtual visits to create hybrid studies. This model will be best suited for Phase III and IV studies. VirTrial enables higher performance by clinical trial sites, greater accessibility to trials for patients, and improved outcomes for pharmaceutical companies. Working together we can bring better medications to market more quickly. To learn more about VirTrial, visit https://www.VirTrial.com.
FierceMarkets, a division of Questex, LLC, is a leader in B2B e-media, providing information and marketing services in the telecommunications, life sciences, healthcare, IT, energy, government, finance, and retail industries through its portfolio of email newsletters, websites, webinars and live events. Every business day, FierceMarkets’ wide array of digital publications reaches more than 2 million executives in more than 100 countries.
Published from Fremont, California, CIOReview is a print magazine that explores and understands the plethora of ways adopted by firms to execute the smooth functioning of their businesses. A distinguished panel comprising of CEOs, CIOs, IT-VPs including CIOReview editorial board finalized the “20 Most Promising Pharma and Life Sciences Tech Solution Providers - 2018” and shortlisted the best vendors and consultants.